Emergent BioSolutions Secures ~$54M Contract To Provide CNJ-016 Vaccinia Immune Globulin Intravenous To U. S. Department of Health And Human Services' Administration For Strategic Preparedness And Response For Smallpox Preparedness; Gets New $6.6M Incremental Orders With Undisclosed Global Federal Partner For ACAM2000 - Emergent BioSolutions (NYSE:EBS)
Published on March 25, 2026.
The world's largest private company, Emergent BioSolutions, has secured a $54M contract with the Department of Health and Human Services (DHS) for providing the services for strategic preparedness and response to smallpox outbreaks. The company also received a $6.6M in additional orders from an undisclosed global government.
Related Articles
$1000 Invested In Intuit 20 Years Ago Would Be Worth This Much Today - Intuit (NASDAQ:INTU)
Athrope, or "We're not yet" £10,000, would be worth $16,000 today if you bought Intuit 20 years ago;
Hawley’s push to revoke abortion pill approval picks up steam
Attorney General Robert Hawley is pushing for a bill to ban mifepristone for use in abortions, citing safety concerns and the widespread availability of the drug.
$1000 Invested In Nucor 5 Years Ago Would Be Worth This Much Today - Nucor (NYSE:NUE)
Athyr T. S. N. uniquely known as "Southeastern" (N. uniquely) is the name of the day: